Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Jan 31 2018

Full Issue

Different Takes: Will Amazon's Venture Be A Breakthrough In Lowering Healthcare Costs?

Editorial pages feature writings on the new initiative between Amazon, JP Morgan and Berkshire Hathaway Inc.

Los Angeles Times: Universal Coverage, Courtesy Of The Corporate World? It's Possible

Took 'em long enough. After decades of government leaders fumbling efforts to introduce some rational thinking to the over $3-trillion U.S. healthcare system, the corporate world has finally stepped in with an initiative that, in the best of all possible worlds, could provide a breakthrough that shows the way to universal coverage. (David Lazarus, 1/30)

The New York Times: Can Amazon And Friends Handle Health Care? There’s Reason For Doubt

The announcement on Tuesday that Amazon, JPMorgan Chase and Berkshire Hathaway would be joining forces to create a health care company moved stock markets and prompted optimistic predictions of major reform in a notoriously complex industry. But while the three companies bring successful management, technological expertise and substantial capital to the venture, many health industry experts expressed doubts about whether their results would match their ambition. (Margot Sanger-Katz and Reed Abelson, 1/30)

Bloomberg: Can Amazon Transform Health Care? It's Not A Crazy Idea

While the initial focus will be on technology, and the efforts will initially be aimed only at employees of the three firms, one suspects that the ambitions are slightly bigger: building a business that can somehow tamp down the pressures that drive health-care costs ever upward. In remaking the market for health-care services, they might even divert some small fraction of that gross national spending into their own pockets. (Megan McArdle, 1/30)

Bloomberg: Amazon/Berkshire/JPMorgan Health Venture: Incumbents Should Fear

The great and oft-heralded Amazon.com Inc. foray into health care is here, and it's not what we expected. The company isn't diving headlong into drug distribution or becoming a pharmacy benefit manager (PBM). Along with JPMorgan Chase & Co. and Berkshire Hathaway Inc., it announced a more interesting idea Tuesday -- a new company aimed at lowering the cost of employee health coverage. Though no one sector will face the full wrath of Bezos, this joint venture is a potential competitive threat to all of health care's many middlemen. (Max Nisen, 1/30)

Bloomberg: JPMorgan Health Venture Poses A Hazard To Its Deal Fees 

The disruptive venture creates a conflict that may be hard to ignore for key executives at companies like UnitedHealth Group Inc., Humana Inc. and Express Scripts Holding Co., who may ice out JPMorgan's bankers when it comes to seeking future transaction or capital markets advice. After all, why pad the profits of a firm whose actions have the ability to potentially shave billions of dollars from respective market values? (Gillian Tan, 1/30)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF